Gyre Therapeutics (GYRE) Inventory Average: 2009-2025
Historic Inventory Average for Gyre Therapeutics (GYRE) over the last 3 years, with Sep 2025 value amounting to $8.9 million.
- Gyre Therapeutics' Inventory Average rose 47.45% to $8.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.9 million, marking a year-over-year increase of 47.45%. This contributed to the annual value of $5.3 million for FY2024, which is 2.07% up from last year.
- Gyre Therapeutics' Inventory Average amounted to $8.9 million in Q3 2025, which was up 5.83% from $8.4 million recorded in Q2 2025.
- In the past 5 years, Gyre Therapeutics' Inventory Average ranged from a high of $8.9 million in Q3 2025 and a low of $4.6 million during Q1 2024.
- Its 2-year average for Inventory Average is $6.7 million, with a median of $6.4 million in 2024.
- Data for Gyre Therapeutics' Inventory Average shows a peak YoY skyrocketed of 58.30% (in 2025) over the last 5 years.
- Over the past 2 years, Gyre Therapeutics' Inventory Average (Quarterly) stood at $6.4 million in 2024, then skyrocketed by 47.45% to $8.9 million in 2025.
- Its last three reported values are $8.9 million in Q3 2025, $8.4 million for Q2 2025, and $7.1 million during Q1 2025.